Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-2024 | 10-2023 | 10-2022 | 10-2021 | 10-2020 | |
| Sales | 4 | 12 | 0 | 0 | 0 |
| Cost of Goods | 3 | 9 | N/A | N/A | 0 |
| Gross Profit | 1 | 3 | N/A | N/A | 0 |
| Operating Expenses | 242 | 884 | 1,031 | 1,655 | 715 |
| Operating Income | -241 | -881 | -1,031 | -1,655 | -715 |
| Interest Expense | 121 | 52 | 11 | 2 | 3 |
| Other Income | 289 | -3,462 | -32 | 4 | 0 |
| Pre-tax Income | -73 | -4,396 | -1,074 | -1,653 | -719 |
| Net Income Continuous | -73 | -4,396 | -1,074 | -1,653 | -719 |
| Net Income | $-73 | $-4,396 | $-1,074 | $-1,653 | $-719 |
| EPS Basic Total Ops | 0.00 | -0.07 | -0.02 | -0.03 | -0.02 |
| EPS Basic Continuous Ops | 0.00 | -0.07 | -0.02 | -0.03 | -0.02 |
| EPS Diluted Total Ops | 0.00 | -0.07 | -0.02 | -0.03 | -0.02 |
| EPS Diluted Continuous Ops | 0.00 | -0.07 | -0.02 | -0.03 | -0.02 |
| EBITDA(a) | $49 | $-3,796 | $-499 | $-1,114 | $-354 |